MORETTINI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 207
NA - Nord America 176
AS - Asia 63
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 449
Nazione #
US - Stati Uniti d'America 176
IT - Italia 76
IE - Irlanda 40
HK - Hong Kong 33
SE - Svezia 28
AT - Austria 22
CH - Svizzera 13
JO - Giordania 12
CN - Cina 11
NL - Olanda 8
BE - Belgio 6
DE - Germania 5
RU - Federazione Russa 4
IN - India 3
GB - Regno Unito 2
TR - Turchia 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
FR - Francia 1
IR - Iran 1
NG - Nigeria 1
SG - Singapore 1
UA - Ucraina 1
Totale 449
Città #
Dublin 40
Chandler 30
Ashburn 29
Hong Kong 25
Fairfield 18
Florence 16
Vienna 15
Bern 13
Amsterdam 8
Houston 8
Altamura 6
Brussels 6
Lawrence 6
New York 6
Princeton 6
Sant'elpidio A Mare 6
Siena 6
Buffalo 5
Cambridge 4
Moscow 4
Napoli 4
Shanghai 4
Washington 4
Wilmington 4
Woodbridge 4
Ann Arbor 3
Beijing 3
Boardman 3
Boston 3
Medford 3
Avellino 2
Bremen 2
Campi Bisenzio 2
Campomorone 2
Chengdu 2
Fucecchio 2
Nashik 2
San Diego 2
San Giovanni Valdarno 2
San Jose 2
Abenberg 1
Andover 1
Catanzaro 1
Cedar Knolls 1
Chicago 1
Hangzhou 1
Hillsboro 1
Jacksonville 1
Karur 1
Lagos 1
Le Havre 1
Leawood 1
Monteriggioni 1
Nagold 1
New Bedfont 1
Norwalk 1
Prescot 1
Scandicci 1
Seattle 1
Specchia 1
Sydney 1
São Paulo 1
Totale 334
Nome #
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 108
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients 86
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy 53
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection 46
Effectiveness of Tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real life study 43
Euthyroid sick syndrome as an early surrogate marker of poor outcome in mild SARS‑CoV‑2 disease 38
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 32
Careggi Re-Engineered Discharge project: standardize discharge and improve care coordination between healthcare professionals 28
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 12
Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes 11
SSRIs in the course of COVID-19 pneumonia: Evidence of effectiveness of antidepressants on acute inflammation. A retrospective study 10
Totale 467
Categoria #
all - tutte 2.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202176 0 0 21 15 8 2 1 11 3 2 8 5
2021/202251 4 1 0 2 5 4 2 4 3 1 12 13
2022/2023196 10 31 11 7 16 32 30 13 23 4 4 15
2023/2024144 6 13 15 11 11 23 5 50 10 0 0 0
Totale 467